Biblio

Export 644 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is J  [Clear All Filters]
2017
E. L. Granholm, Panizzon, M. S., Elman, J. A., Jak, A. J., Hauger, R. L., Bondi, M. W., Lyons, M. J., Franz, C. E., and Kremen, W. S., “Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1419-1428, 2017.
W. - S. Jin, Le Bu, X. -, Wang, Y. - R., Li, L., Li, W. - W., Liu, Y. - H., Zhu, C., Yao, X. - Q., Chen, Y., Gao, C. - Y., Zhang, T., Gao, C. - Y., Zhou, H. - D., Zeng, F., and Wang, Y. - J., “Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 919-925, 2017.
P. Johansson, Almqvist, E. G., Bjerke, M., Wallin, A., Johansson, J. - O., Andreasson, U., Blennow, K., Zetterberg, H., and Svensson, J., “Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
P. Johansson, Almqvist, E. G., Bjerke, M., Wallin, A., Johansson, J. - O., Andreasson, U., Blennow, K., Zetterberg, H., and Svensson, J., “Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
L. Jacob, Bohlken, J., and Kostev, K., “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., “Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., “Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
B. - E. Kirsebom, Espenes, R., Waterloo, K., Hessen, E., Johnsen, S. Harald, Bråthen, G., Aarsland, D., and Fladby, T., “Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1621-1631, 2017.
C. K. Barha, Hsiung, G. - Y. R., Best, J. R., Davis, J. C., Eng, J. J., Jacova, C., Lee, P. E., Munkacsy, M., Cheung, W., and Liu-Ambrose, T., “Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1397-1410, 2017.
M. Wei, Zhao, B., Huo, K., Deng, Y., Shang, S., Liu, J., Li, Y., Ma, L., Jiang, Y., Dang, L., Chen, C., Wei, S., Zhang, J., Yang, H., Gao, F., and Qu, Q., “Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.”, J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.
L. Wu, Liu, J., Sha, L., Wang, X., Li, J., Dong, J., and Jia, J., “Sporadic Cases with Novel Mutations and Pedigree in Hereditary Leukoencephalopathy with Axonal Spheroids.”, J Alzheimers Dis, vol. 56, no. 3, pp. 893-898, 2017.
S. Kumar Jha, Jha, N. Kumar, Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., and Kumar, P., “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
S. Kumar Jha, Jha, N. Kumar, Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., and Kumar, P., “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
J. Tao, Liu, J., Liu, W., Huang, J., Xue, X., Chen, X., Wu, J., Zheng, G., Chen, B., Li, M., Sun, S., Jorgenson, K., Lang, C., Hu, K., Chen, S., Chen, L., and Kong, J., “Tai Chi Chuan and Baduanjin Increase Grey Matter Volume in Older Adults: A Brain Imaging Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 389-400, 2017.
Y. Li, Li, Z. - X., Jin, T., Wang, Z. - Y., and Zhao, P., “Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.”, J Alzheimers Dis, vol. 57, no. 2, pp. 395-409, 2017.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., “Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
M. Bilgel, Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., and Jedynak, B. M., “Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1335-1347, 2017.
S. L. Siedlak, Jiang, Y., Huntley, M. L., Wang, L., Gao, J., Xie, F., Liu, J., Su, B., Perry, G., and Wang, X., “TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1027-1033, 2017.
D. Li, Hu, N., Yu, Y., Zhou, A., Li, F., and Jia, J., “Trajectories of Multidimensional Caregiver Burden in Chinese Informal Caregivers for Dementia: Evidence from Exploratory and Confirmatory Factor Analysis of the Zarit Burden Interview.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1317-1325, 2017.
C. Y. Liu, Ohki, Y., Tomita, T., Osawa, S., Reed, B. R., Jagust, W., Van Berlo, V., Jin, L. - W., Chui, H. C., Coppola, G., and Ringman, J. M., “Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1035-1041, 2017.
C. Y. Liu, Ohki, Y., Tomita, T., Osawa, S., Reed, B. R., Jagust, W., Van Berlo, V., Jin, L. - W., Chui, H. C., Coppola, G., and Ringman, J. M., “Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1035-1041, 2017.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
K. Krishnan, Machulda, M. M., Whitwell, J. L., Butts, A. M., Duffy, J. R., Strand, E. A., Senjem, M. L., Spychalla, A. J., Jack, C. R., Lowe, V. J., and Josephs, K. A., “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
K. Krishnan, Machulda, M. M., Whitwell, J. L., Butts, A. M., Duffy, J. R., Strand, E. A., Senjem, M. L., Spychalla, A. J., Jack, C. R., Lowe, V. J., and Josephs, K. A., “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.

Pages